Glucocorticoid Release Is Involved In Myeloid-Derived Suppressor Cell Accumulation In The Spleen Following Polytrauma

Liang Cheng,Jia Xu,Yimin Chai,Chunyang Wang,Pei Han
2016-01-01
Abstract:Myeloid-derived suppressor cells (MDSCs) accumulate in the spleen and suppress T cell activity after polytrauma. Glucocorticoid (GC) release is activated by the hypothalamic-pituitary-adrenal (HPA) axis following polytrauma and GCs have been shown to induce a monocyte subset which resembles MDSCs in vitro. We investigated the effect of GCs on MDSC expansion following polytrauma. Thirty-six Sprague-Dawley rats were subjected to experimental polytrauma. Animals were sacrificed at 2, 6, 12, 18, 24 or 48 h postoperatively, and blood, spleen and bone marrow were collected for analysis. Dexamethasone was given to naive rats (n = 6), which were then sacrificed 2 h after administration. Another group of rats received RU486 30 min before polytrauma (n = 6) and were then sacrificed 2 h postoperatively. Serum concentrations of corticosterone were measured using an ELISA kit. Expansion of MDSCs was assessed by flow cytometry. Incorporation of [H-3] thymidine was used to measure T cell proliferation. The results showed that MDSCs were mobilized in the bone marrow, increased in the blood and accumulated in the spleen after polytrauma (P < 0.05) and this accumulation showed a linear correlation with the release of GCs (P < 0.05). MDSCs induced by polytrauma suppressed T cell proliferation. Further, dexamethasone treatment of naive rats enhanced the MDSC expansion while RU486 administered before polytrauma attenuated it (P < 0.05). These results suggest that the release of GCs following polytrauma is involved in MDSC expansion, which suppresses T cell activity. These findings provide new insight into GC regulation of immune cells.
What problem does this paper attempt to address?